Quick Answer
Liminatus Pharma, Inc. reported R&D Expense of $2.69 million for fiscal year 2024.
Liminatus Pharma, Inc. R&D Expense — Annual History
| Fiscal Year | R&D Expense | YoY Change |
|---|---|---|
| 2024 | $2.69M | — |
Quarterly R&D Expense
| Quarter Ending | R&D Expense | YoY | QoQ |
|---|---|---|---|
| September 30, 2024 | $357.1K | — | -50.0% |
| June 30, 2024 | $714.1K | — | — |
- The most recent figure is from Liminatus Pharma, Inc.’s fiscal year 2025 report (Form 10-K), filed with the SEC on March 31, 2026.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: